US FDA Making BsUFA III Regulatory Science Grants Available Early

Up to $1m per year per award is available for projects that address significant issues with biosimilar or interchangeable product development.

Beaker with US money
The biosimilar regulatory science research pilot program is intended to resemble the FDA program already created for generic drugs. • Source: Alamy

The US Food and Drug Administration is soliciting applications for biosimilar regulatory science grants now even though the program most likely will not be created for a few more months.

The grants, available under the upcoming biosimilar user fee program reauthorization, are intended to “support research projects that enhance biosimilar...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Biosimilars

More from Biosimilars & Generics